This is the authors' abstract. We don't add key points for this paper.
Neoadjuvant T-DXd-THP demonstrated statistically significant and clinically meaningful pCR benefit and improved safety versus ddAC-THP.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Harbeck et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: